Literature DB >> 25500969

A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties.

Madeeha Aqil1, Kim M Elseth, Ashok Arjunakani, Philip Nebres, Courtney P Amegashie, Devang H Thanki, Premal B Desai, James A Radosevich.   

Abstract

The migration and adhesion properties of tumors affect their metastatic rate. In the present study, we investigated carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 1, 5, and 6 expression in high nitric oxide (HNO)-adapted lung cancer cells compared to parent cells. We observed high transcript levels of CEACAM 1 (4S, 4L), CEACAM 5, and CEACAM 6 in HNO cells compared to parent cells. However, the surface expression was low in HNO cells. Interestingly, the intracellular protein levels were high for these three CEACAMs. We confirmed these results with immunohistochemical experiments. Further, the adhesion and migration assays showed reduced clumping in HNO-adapted A549 (A549-HNO) cells and faster migration rates, respectively. These results document the altered adhesion and migration properties of cells adapted to HNO. Further, our studies also indicate a dynamic regulation of CEACAM protein expression and surface transport in HNO cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25500969     DOI: 10.1007/s13277-014-2789-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  55 in total

1.  Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines.

Authors:  Yaroslav R Yarmolyuk; Benjamin J Vesper; William A Paradise; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-10-23

2.  Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck.

Authors:  B G Bentz; G K Haines; M W Lingen; H J Pelzer; D G Hanson; J A Radosevich
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-08       Impact factor: 1.547

3.  Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.

Authors:  Eckart Laack; Haleh Nikbakht; Anja Peters; Christian Kugler; Yvonne Jasiewicz; Lutz Edler; Jens Brümmer; Udo Schumacher; Dieter Kurt Hossfeld
Journal:  J Clin Oncol       Date:  2002-11-01       Impact factor: 44.544

Review 4.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Authors:  S Hammarström
Journal:  Semin Cancer Biol       Date:  1999-04       Impact factor: 15.707

5.  CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo.

Authors:  Marica Gemei; Peppino Mirabelli; Rosa Di Noto; Claudia Corbo; Antonino Iaccarino; Anna Zamboli; Giancarlo Troncone; Gennaro Galizia; Eva Lieto; Luigi Del Vecchio; Francesco Salvatore
Journal:  Cancer       Date:  2012-10-01       Impact factor: 6.860

6.  Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors.

Authors:  H De Vitto; B S Mendonça; K M Elseth; B J Vesper; E A Portari; C V M Gallo; W A Paradise; F D Rumjanek; J A Radosevich
Journal:  Tumour Biol       Date:  2012-12-14

7.  Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes.

Authors:  Bernhard B Singer; Inka Scheffrahn; Robert Heymann; Kristmundur Sigmundsson; Robert Kammerer; Björn Obrink
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

8.  Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells.

Authors:  Bernhard B Singer; Inka Scheffrahn; Robert Kammerer; Norbert Suttorp; Suleyman Ergun; Hortense Slevogt
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

9.  Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.

Authors:  J P Tiernan; S L Perry; E T Verghese; N P West; S Yeluri; D G Jayne; T A Hughes
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

10.  Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids.

Authors:  F Toffalorio; E Belloni; M Barberis; G Bucci; L Tizzoni; G Pruneri; C Fumagalli; G Spitaleri; C Catania; F Melotti; P G Pelicci; L Spaggiari; T De Pas
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

View more
  1 in total

1.  Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma.

Authors:  Seung-Myoung Son; Jieun Yun; Sung-Hoon Lee; Hye Sook Han; Young Hyun Lim; Chang Gok Woo; Ho-Chang Lee; Hyung Geun Song; Young-Mi Gu; Hyun-Jun Lee; Ok-Jun Lee
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.